Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16259459 | 0.91 | TSHR (0.47) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL28772905 | 0.91 | CYP3A4 (0.47) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL28473582 | 0.91 | CYP3A4 (0.47) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL827333 | 0.86 | TSHR (0.50) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL15430 | 0.84 | CYP3A4 (0.70) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL11883143 | 0.83 | CYP3A4 (0.52) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL10647355 | 0.83 | CYP3A4 (0.52) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL11025696 | 0.82 | CYP3A4 (0.50) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL16545330 | 0.82 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL2603375 | 0.82 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11359224-B2 | Enzyme-immobilized porous membrane and preparation method of antibiotics using the same | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-06-14 | — | — | US | claimed |
| US-9840701-B2 | Porous membrane having immobilized enzyme, porous membrane composite including the same, and preparation method thereof | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-12-12 | — | — | US | claimed |
| US-9637611-B2 | 3D covalent molecular network nanocapsule and preparing method thereof | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-05-02 | — | — | US | claimed |
| US-20140312278-A1 | 3D COVALENT MOLECULAR NETWORK NANOCAPSULE AND PREPARING METHOD THEREOF | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2014-10-23 | — | — | US | claimed |
| EP-2992947-B1 | METHOD FOR THE PREPARATION OF MICROPOROUS ORGANIC MEMBRANES, MICROPOROUS ORGANIC MEMBRANES AND USE OF SAME | KARLSRUHER INST TECHNOLOGIE (DE) | 2023-03-01 | — | — | EP | disclosed |
| US-11359224-B2 | Enzyme-immobilized porous membrane and preparation method of antibiotics using the same | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-06-14 | — | — | US | disclosed |
| US-20200063175-A1 | ENZYME-IMMOBILIZED POROUS MEMBRANE AND PREPARATION METHOD OF ANTIBIOTICS USING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2020-02-27 | — | — | US | disclosed |
| US-10202596-B2 | Porous membrane having immobilized enzyme, porous membrane composite including the same, and preparation method thereof | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2019-02-12 | — | — | US | disclosed |
| US-9840701-B2 | Porous membrane having immobilized enzyme, porous membrane composite including the same, and preparation method thereof | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-12-12 | — | — | US | disclosed |
| US-20170144114-A1 | COMPOSITE MEMBRANE AND METHOD OF MANUFACTURING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-05-25 | — | — | US | disclosed |
| US-9637611-B2 | 3D covalent molecular network nanocapsule and preparing method thereof | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-05-02 | — | — | US | disclosed |
| US-20170101660-A1 | ENZYME-IMMOBILIZED POROUS MEMBRANE AND PREPARATION METHOD OF ANTIBIOTICS USING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-04-13 | — | — | US | disclosed |
| EP-2992947-A1 | METHOD FOR THE PREPARATION OF MICROPOROUS ORGANIC MEMBRANES, MICROPOROUS ORGANIC MEMBRANES AND USE OF SAME | Karlsruher Institut für Technologie (DE) | 2016-03-09 | — | — | EP | disclosed |
| US-20150099288-A1 | POROUS MEMBRANE HAVING IMMOBILIZED ENZYME, POROUS MEMBRANE COMPOSITE INCLUDING THE SAME, AND PREPARATION METHOD THEREOF | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2015-04-09 | — | — | US | disclosed |
| US-20150059579-A1 | GAS SEPARATION MEMBRANE FOR CARBON DIOXIDE AND PREPARATION METHOD THEREOF | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2015-03-05 | — | — | US | disclosed |
| US-20140312278-A1 | 3D COVALENT MOLECULAR NETWORK NANOCAPSULE AND PREPARING METHOD THEREOF | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2014-10-23 | — | — | US | disclosed |
| US-8815967-B2 | Porous polyurea material and methods for preparing the same | Gwangju Institute of Science an Technology (KR) | 2014-08-26 | — | — | US | disclosed |
| US-8815967-B2 | Porous polyurea material and methods for preparing the same | Gwangju Institute of Science an Technology (KR) | 2014-08-26 | — | — | US | disclosed |
| US-20120095123-A1 | POROUS POLYUREA MATERIAL AND METHODS FOR PREPARING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2012-04-19 | — | — | US | disclosed |
| US-3971785-A | POLYAMINE, POLYURETHANE | W. R. GRACE & CO. (US) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101660-A1 | ENZYME-IMMOBILIZED POROUS MEMBRANE AND PREPARATION METHOD OF ANTIBIOTICS USING THE SAME | ADA, ANPEP, PEPD | CYP3A4 360/4885TSHR 2997/4885MAPK1 4231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.